vs
MANNKIND CORP（MNKD）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是MANNKIND CORP的1.9倍（$217.4M vs $112.0M），Rapid7, Inc.净利率更高（1.4% vs -14.2%，领先15.7%），MANNKIND CORP同比增速更快（45.8% vs 0.5%），Rapid7, Inc.自由现金流更多（$36.4M vs $-10.0M），过去两年MANNKIND CORP的营收复合增速更高（30.0% vs 3.0%）
曼凯德公司是一家生物制药企业，成立于1991年2月，总部位于美国康涅狄格州丹伯里，专注于糖尿病、肺动脉高压等疾病治疗药物的研发、生产及商业化推广，致力于为相关患者提供创新的治疗方案。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
MNKD vs RPD — 直观对比
营收规模更大
RPD
是对方的1.9倍
$112.0M
营收增速更快
MNKD
高出45.3%
0.5%
净利率更高
RPD
高出15.7%
-14.2%
自由现金流更多
RPD
多$46.4M
$-10.0M
两年增速更快
MNKD
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.0M | $217.4M |
| 净利润 | $-15.9M | $3.1M |
| 毛利率 | 87.6% | 68.9% |
| 营业利润率 | -6.9% | 1.0% |
| 净利率 | -14.2% | 1.4% |
| 营收同比 | 45.8% | 0.5% |
| 净利润同比 | -314.9% | 44.1% |
| 每股收益（稀释后） | $-0.05 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNKDRPD
| Q4 25 | $112.0M | $217.4M | ||
| Q3 25 | $82.1M | $218.0M | ||
| Q2 25 | $76.5M | $214.2M | ||
| Q1 25 | $78.4M | $210.3M | ||
| Q4 24 | $76.8M | $216.3M | ||
| Q3 24 | $70.1M | $214.7M | ||
| Q2 24 | $72.4M | $208.0M | ||
| Q1 24 | $66.3M | $205.1M |
净利润MNKDRPD
| Q4 25 | $-15.9M | $3.1M | ||
| Q3 25 | $8.0M | $9.8M | ||
| Q2 25 | $668.0K | $8.3M | ||
| Q1 25 | $13.2M | $2.1M | ||
| Q4 24 | $7.4M | $2.2M | ||
| Q3 24 | $11.6M | $15.4M | ||
| Q2 24 | $-2.0M | $6.5M | ||
| Q1 24 | $10.6M | $1.4M |
毛利率MNKDRPD
| Q4 25 | 87.6% | 68.9% | ||
| Q3 25 | 94.5% | 70.2% | ||
| Q2 25 | 94.0% | 70.6% | ||
| Q1 25 | 95.2% | 71.7% | ||
| Q4 24 | 93.7% | 69.5% | ||
| Q3 24 | 95.4% | 70.6% | ||
| Q2 24 | 92.3% | 70.7% | ||
| Q1 24 | 94.2% | 70.3% |
营业利润率MNKDRPD
| Q4 25 | -6.9% | 1.0% | ||
| Q3 25 | 23.0% | 2.7% | ||
| Q2 25 | 6.9% | 1.6% | ||
| Q1 25 | 28.5% | -0.0% | ||
| Q4 24 | 34.5% | 3.4% | ||
| Q3 24 | 18.2% | 6.0% | ||
| Q2 24 | 22.9% | 2.5% | ||
| Q1 24 | 25.2% | 4.7% |
净利率MNKDRPD
| Q4 25 | -14.2% | 1.4% | ||
| Q3 25 | 9.7% | 4.5% | ||
| Q2 25 | 0.9% | 3.9% | ||
| Q1 25 | 16.8% | 1.0% | ||
| Q4 24 | 9.7% | 1.0% | ||
| Q3 24 | 16.5% | 7.2% | ||
| Q2 24 | -2.8% | 3.1% | ||
| Q1 24 | 16.0% | 0.7% |
每股收益（稀释后）MNKDRPD
| Q4 25 | $-0.05 | $0.05 | ||
| Q3 25 | $0.03 | $0.15 | ||
| Q2 25 | $0.00 | $0.13 | ||
| Q1 25 | $0.04 | $0.03 | ||
| Q4 24 | $0.03 | $0.08 | ||
| Q3 24 | $0.04 | $0.21 | ||
| Q2 24 | $-0.01 | $0.09 | ||
| Q1 24 | $0.04 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $171.3M | $474.7M |
| 总债务越低越好 | $354.6M | — |
| 股东权益账面价值 | $-51.0M | $154.7M |
| 总资产 | $792.2M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MNKDRPD
| Q4 25 | $171.3M | $474.7M | ||
| Q3 25 | $260.0M | $407.1M | ||
| Q2 25 | $179.0M | $511.7M | ||
| Q1 25 | $181.5M | $493.5M | ||
| Q4 24 | $197.3M | $521.7M | ||
| Q3 24 | $251.6M | $443.7M | ||
| Q2 24 | $247.8M | $442.6M | ||
| Q1 24 | $300.7M | $411.7M |
总债务MNKDRPD
| Q4 25 | $354.6M | — | ||
| Q3 25 | $109.7M | — | ||
| Q2 25 | $36.2M | — | ||
| Q1 25 | $36.1M | — | ||
| Q4 24 | $36.1M | — | ||
| Q3 24 | $227.9M | — | ||
| Q2 24 | $227.6M | — | ||
| Q1 24 | $264.1M | — |
股东权益MNKDRPD
| Q4 25 | $-51.0M | $154.7M | ||
| Q3 25 | $-44.6M | $127.2M | ||
| Q2 25 | $-55.0M | $90.4M | ||
| Q1 25 | $-58.6M | $52.7M | ||
| Q4 24 | $-78.8M | $17.7M | ||
| Q3 24 | $-209.9M | $-5.1M | ||
| Q2 24 | $-225.8M | $-52.6M | ||
| Q1 24 | $-230.0M | $-86.4M |
总资产MNKDRPD
| Q4 25 | $792.2M | $1.7B | ||
| Q3 25 | $494.6M | $1.7B | ||
| Q2 25 | $411.7M | $1.6B | ||
| Q1 25 | $410.1M | $1.6B | ||
| Q4 24 | $393.8M | $1.7B | ||
| Q3 24 | $464.2M | $1.6B | ||
| Q2 24 | $443.8M | $1.5B | ||
| Q1 24 | $480.9M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | $36.4M |
| 自由现金流率自由现金流/营收 | -8.9% | 16.8% |
| 资本支出强度资本支出/营收 | 1.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | $13.7M | $146.2M |
8季度趋势，按日历期对齐
经营现金流MNKDRPD
| Q4 25 | $-8.0M | $37.6M | ||
| Q3 25 | $23.6M | $39.0M | ||
| Q2 25 | $8.9M | $47.5M | ||
| Q1 25 | $-6.4M | $29.8M | ||
| Q4 24 | $22.6M | $63.8M | ||
| Q3 24 | $9.3M | $44.0M | ||
| Q2 24 | $3.8M | $32.9M | ||
| Q1 24 | $6.7M | $31.1M |
自由现金流MNKDRPD
| Q4 25 | $-10.0M | $36.4M | ||
| Q3 25 | $22.5M | $34.8M | ||
| Q2 25 | $7.8M | $46.6M | ||
| Q1 25 | $-6.7M | $28.4M | ||
| Q4 24 | $19.7M | $62.6M | ||
| Q3 24 | $7.9M | $42.6M | ||
| Q2 24 | $861.0K | $32.6M | ||
| Q1 24 | $4.3M | $30.4M |
自由现金流率MNKDRPD
| Q4 25 | -8.9% | 16.8% | ||
| Q3 25 | 27.4% | 16.0% | ||
| Q2 25 | 10.2% | 21.8% | ||
| Q1 25 | -8.6% | 13.5% | ||
| Q4 24 | 25.7% | 28.9% | ||
| Q3 24 | 11.3% | 19.9% | ||
| Q2 24 | 1.2% | 15.7% | ||
| Q1 24 | 6.5% | 14.8% |
资本支出强度MNKDRPD
| Q4 25 | 1.8% | 0.5% | ||
| Q3 25 | 1.4% | 1.9% | ||
| Q2 25 | 1.5% | 0.4% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 3.8% | 0.5% | ||
| Q3 24 | 2.0% | 0.6% | ||
| Q2 24 | 4.1% | 0.1% | ||
| Q1 24 | 3.6% | 0.3% |
现金转化率MNKDRPD
| Q4 25 | — | 12.01× | ||
| Q3 25 | 2.96× | 3.97× | ||
| Q2 25 | 13.40× | 5.70× | ||
| Q1 25 | -0.48× | 14.14× | ||
| Q4 24 | 3.05× | 29.36× | ||
| Q3 24 | 0.81× | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | 0.63× | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNKD
| Products | $50.4M | 45% |
| Royalty | $33.6M | 30% |
| Afrezza | $22.9M | 20% |
| V Go | $4.3M | 4% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
